The EBMT Handbook

Hematopoietic Stem Cell Transplantation and Cellular Therapies
 
 
Springer (Verlag)
  • erschienen am 21. Dezember 2018
 
  • Buch
  • |
  • Hardcover
  • |
  • XL, 702 Seiten
978-3-030-02277-8 (ISBN)
 

This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field.

Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies.

This book provides an unparalleled description of current practices to enhance readers' knowledge and practice skills.

new edition. 2019
  • Englisch
  • Cham
  • |
  • Schweiz
Springer International Publishing
  • Für Beruf und Forschung
  • Überarbeitete Ausgabe
  • 18 s/w Abbildungen, 38 farbige Abbildungen
  • |
  • 20 schwarz-weiße und 30 farbige Abbildungen, Bibliographie
  • Höhe: 261 mm
  • |
  • Breite: 184 mm
  • |
  • Dicke: 40 mm
  • 1832 gr
978-3-030-02277-8 (9783030022778)
10.1007/978-3-030-02278-5
weitere Ausgaben werden ermittelt
Enric Carreras, MD, PhD, the handbook Project Leader is Director of the Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute in Barcelona, Spain Carlo Dufour, MD, PhD, is Chairperson SAAWP Education Representative at Scientific Council Education, Director Hematology Unit, ay IRCCS Giannina Gaslini, Genoa, Italy Nicolaus Kröger MD, PhD, is the current EBMT President, Scientific Council Chair, Professor of Medicine and Medical Director of the Department of Stem Cell Transplantation at the University Medical Center, Hamburg - Eppendorf, Germany Mohamad Mohty, MD, PhD , is past-president of the EBMT, Chairperson ALWP, Professor of Hematology and Head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie, Paris, France
Part I. Chapter. 1 HSCT: Historical perspectiveStorb, RChapter. 2 The EBMT: History, present & futureApperley, J; Gratwohl, A; Mohty, MChapter. 3 The donor registries (organization, regulation, international search...) Madrigal, A; Evseeva, IrinaChapter. 4 The HSCT Unit (minimal requirements, data manager trasplant coordinator) Aljurf, M; Niederwieser, Dietger; Rasheed, WalidChapter. 5 JACIE accreditation of HSCT programs Saccardi, RChapter. 6Statistics in HSCT and Cellular Therapies Labopin, M; Iacobelli, S; de Wreede, Liesbeth; Szydlo, Richard Part II. Chapter. 7 Biological properties of HSC: scientific basis for HSCT Chabannon, C ; Aiuti, MChapter. 8 Biological properties of cells other than HSC (adaptative, abT, Treg, DC. Innete gdT, IELs MSC, NK) Toubert, A; Koehl, U; Bondanza, AChapter. 9 Histocompatibility (main concepts on HLA) K. Fleischhauer; SpieringsChapter. 10 Clinical & biological concepts for mastering Immune reconstitution after HSCTBoelens, J; Kuball, J Part III. Chapter. 11 Evaluation and counselling of candidates Rambaldi, AChapter. 12 Donor selection for adults and pediatrics Ayuk, F; Balduzzi, AChapter. 13 Conditioning (MAC, RIC, NMA; including TBI) Nagler, AChapter. 14 Bone marrow harvest Gorin, ClaudeChapter. 15 Mobilization and collection of HSC Hübel, KChapter. 16 Collection of HSC in childrenPeters, C; Witt, VolkerChapter. 17 Processing, cryopreserving, and controlling the quality of HSC Wuchter, PatrickChapter. 18 Procurement and management of cord bloodRocha, V; Querol, SChapter. 19 Graft manipulation Handgretinger, RChapter. 20 Documentation of engraftment and chimerism after HSCT Bader, PChapter. 21 Short and long term controls after HSCT Shimoni, A Part IV. Chapter. 22 Vascular access Cesaro, SChapter. 23 Transfusion supportSchrezenmeier, HChapter. 24 Fluid and electrolyte managementMasszi, T; Baumgartner, AnnicChapter. 25 GVHD prophylaxis (immunosuppression) Socié, GChapter. 26 Management ATG (SIRS) F. BonifaziChapter. 27 Infections control and isolation procedures Mikulska, M Chapter. 28 Pain management Ahmedzai, SHChapter. 29 Specific aspects of management in childrenCastagnola, Elio; Riccardi, FChapter. 30 Vaccinations de la Cámara, RafaChapter. 31 Psychological support Moreno, E ; Schulz-Kindermann, F ; Polomeni, AliceChapter. 32 Relevant pharmacological interaction Bauters, TChapter. 33 Role of nursing in HSCT Babic, A; Murray, JChapter. 34 Ethical issues in HSCT Dalle, JH; El-Ghariani, K Part V. Chapter. 35 Quality assessment of life after HSCT for pediatric and adults Barata, Anna; Jim, HeatherChapter. 36 Neutropenic fever Mikulska, M Chapter. 37 Bacterial infections Averbuch, DChapter. 38 Invasive fungal infections Maertens, JChapter. 39 Viral infections (CMC, EVB, VZV, HSV, HHV6, Resp. V, HCV, HBV...) & anti-viral cell therapyLjungman, P; Styczynski, J; Einsele, HermannChapter. 40 Other infections in HSCT (Tuberc, Toxo, PCJ, Noc, List.) Martino, RChapter. 41 Bleeding and thrombotic complicationsSavani, BChapter. 42 Graft failureValcárcel , D; Sureda, AChapter. 43 Early complications of endothelial origin Carreras, EChapter. 44 Acute GvHD Greinix, H; Holler, E; Zeiser, RChapter. 45 Chronic GvHD Wolff, D; Lawitschka, AChapter. 46 Post-transplant lymphoproliferative syndromesStyczynski, J ; Giebel, SChapter. 47 Iron overloadAngelucci, EChapter. 48 Secondary neoplasia (other than PTLPS) Tichelli, A Part VI. Chapter. 49 Specific organ complications: Ocular / oral / pulmonary / hepatic Ruutu, T; Hashmi, SChapter. 50 Gastrointestinal complicationsBasak, GChapter. 51 Hemorrhagic cystitis and renal dysfunctionCesaro, SChapter. 52 Pulmonary complications Carreras, EChapter. 53 Neurological complications Duléry, RChapter. 54 Specific organ complications: Skin, hair, musculoskeletal Ayuk, F; Savani, BChapter. 55 Cardiovascular diseases and metabolic syndrome Snowden, J; Greenfield, DChapter. 56 Endocrine, fertility and sexual healthSalooja, N; Shoham, Z; Balduzzi, A Part VII. Chapter. 57 Monitoring MRD in ALL Bader, P; Ossenkoppele, GChapter. 58 Preventing/treating relapse with drugsKröger, N; Mohty, MChapter. 59 Preventing relapse by mean cells (DLI, aBT, subsets, tumour specific T cells) Kuball, J; Falkenburg, JH Fred; Kolb, HJ; Locatelli, FChapter. 60 Cellular therapy (CAR T, TCR T, suicide genes) with management and side effectsBonini, C; Hudecek, Michael; Fehse, Boris; Bondanza, AChapter. 61 Mechanisms of Immune resistance and overcoming immune resistance (checkpoint...)Dazzi, F; Vago, LChapter. 62 Regulatory Aspects of ATMP versus minimally manipulated immune cellsMc Grath, E; Chabannon, C Part VIII. Chapter. 63 At-home HSCT Fernández-Avilés, FChapter. 64 Cord blood HSCT (adults & children) Veys, P; Rocha, V; Sanz, JChapter. 65 Haploidentical HSCT (TCD and TC-repleted)Ciceri, F ; Bacigalupo, AChapter. 66 Photopheresis in adults and pediatrics Greinix, H; Gennery, AChapter. 67 Pediatric aspects of haploidentical HSCT Gennery, A; Bertaina, A; Slatter, M; Lankester, A; Albert, MChapter. 68 Overweight and obese patients Langebrake, C Chapter. 69 HSCT in Elderly patiens Duarte, R Part IX. Chapter. 70 EBMT indication for allo and auto HSCT BOARDChapter. 71 AML in adults (incl APL) Nagler, A; Cornelissen, J; Craddock, C; Sanz, MAChapter. 72 AML in children Gibson, B ; Sauer, MChapter. 73 ALL in adults Marks, D ; Stelljes, MChapter. 74 ALL in children and adolescents Peters, C; Locatelli, F; Bader, PChapter. 75 Myelodysplastic syndromes de Witte, T; Robin, MChapter. 76 Refractory Anemia and JMML in children Niemeyer, CMChapter. 77 Myelodysplastic/myeloproliferative syndromes Onida, F; Chalandon, Y Chapter. 78 Myeloproliferative neoplasms (CML, PM, other MPN) Olavarria E; Kröger, NChapter. 79 Severe aplastic anemia and PNHDufour C; Peffault de la Tour, R; Risitano, Antonio MariaChapter. 80 Fanconi anemia and other hereditary BMF syndromesFioredda, F; Strahm, B; Diaz de Heredia, Cristina; Dalle, JH; Bierings, MarcChapter. 81 Hemoglobinopathies (SCA)Gluckman, E; Abboud, MiguelChapter. 82 Multiple myeloma Mohty, M; Blade, Joan; Bruno, BChapter. 83 Systemic light chain amyloidosis Schönland, S; Minnema, MChapter. 84 POEMS syndrome and disease produced by other monoclonal Igs Cook, G; Rovira, MChapter. 85 Low grade NHL (follicular, MALT, MW) Robinson, S; Kyriacou, CChapter. 86 Chronic lymphoid leukemia Dreger, P; Schetelig, JohannesChapter. 87 Diffuse large B cell NHL Bazarbachi, A; Schmitz, NChapter. 88 Mantle cell lymphoma Dietrich, S; Hermine, OChapter. 89 Other T- and B-aggressive lymphomas (Burkitt, LL, PTCL) & Lymphomas associated to HIVHübel, K; Montoto, SChapter. 90 Hodgkin lymphoma Sureda, A; Martinez, CarmenChapter. 91 Primary immunodeficiency diseasesLankester, A; Gennery, A; Albert, MChapter. 92 Inborn error of metabolism and osteopetrosis Schulz, A; Wynn, RChapter.93 Autoimmune disease Snowden, J; Rovira, M; Alexander, T ; Sharrack, B ; Farge, DChapter.94 Solid tumors (adults and children)Lanza, F; Ladenstein, R AppendixEBMT Registry Ruiz, C; Hewer
This Open Access 7th edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field.

Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies.

This book provides an unparalleled description of current practices to enhance readers' knowledge and practice skills.
DNB DDC Sachgruppen

Sofort lieferbar

53,49 €
inkl. 5% MwSt.
in den Warenkorb